Skip to content
buyWeak

Richard S Levy bought $64k of TARA

director at Protara Therapeutics, Inc.. 20,000 shares at an average of $3.19, traded May 14, 2025, filed May 16, 2025.

Conviction score
33
Value
$64k
20,000 shares
Holdings after
51,000
+65% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $64k at market
    +8
  • Relative to holdings
    Holdings up 65%
    +10
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001213900-25-044871, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 14, 2025POpen-market purchase
Common Stock
+20,000$3.19$64k51,000May 16, 2025

Related signals

Other insiders at Protara Therapeutics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
33Weak
TARAbuy
Protara Therapeutics, Inc.
Richard S Levy
director
$64k
20,000 shares
+65%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Richard S Levy bought $64k of TARA | InsiderTell